Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Patient-Centered Interventions to Improve Adherence to Statins: A Narrative Synthesis of Systematically Identified Studies.

Jörntén-Karlsson M, Pintat S, Molloy-Bland M, Berg S, Ahlqvist M.

Drugs. 2016 Oct;76(15):1447-1465. Review.

2.

Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence.

Lavikainen P, Helin-Salmivaara A, Eerola M, Fang G, Hartikainen J, Huupponen R, Korhonen MJ.

BMJ Open. 2016 Jun 3;6(6):e011306. doi: 10.1136/bmjopen-2016-011306.

3.

Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.

Bai JW, Boulet G, Halpern EM, Lovblom LE, Eldelekli D, Keenan HA, Brent M, Paul N, Bril V, Cherney DZ, Weisman A, Perkins BA.

Cardiovasc Diabetol. 2016 Jan 25;15:14. doi: 10.1186/s12933-015-0318-9.

4.

Lipid-lowering treatment patterns in patients with new cardiovascular events - estimates from population-based register data in Sweden.

Hallberg S, Banefelt J, Fox KM, Mesterton J, Johansson G, Levin LÅ, Sobocki P, Gandra SR.

Int J Clin Pract. 2016 Mar;70(3):222-8. doi: 10.1111/ijcp.12769.

5.

Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence.

Braamskamp MJ, Kusters DM, Avis HJ, Smets EM, Wijburg FA, Kastelein JJ, Wiegman A, Hutten BA.

Paediatr Drugs. 2015 Apr;17(2):159-66. doi: 10.1007/s40272-014-0116-y.

6.

Accuracy of the days' supply and the number of refills allowed recorded in Québec prescription claims databases for inhaled corticosteroids.

Blais L, Vilain A, Kettani FZ, Forget A, Lalonde G, Beauchesne MF, Ducharme FM, Lemière C.

BMJ Open. 2014 Nov 28;4(11):e005903. doi: 10.1136/bmjopen-2014-005903.

7.

Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review.

De Vera MA, Bhole V, Burns LC, Lacaille D.

Br J Clin Pharmacol. 2014 Oct;78(4):684-98. Review.

8.

Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in Finland.

Ruokoniemi P, Sund R, Arffman M, Helin-Salmivaara A, Huupponen R, Keskimäki I, Vehko T, Korhonen MJ.

BMJ Open. 2014 Jun 19;4(6):e005402. doi: 10.1136/bmjopen-2014-005402.

9.

Lipid-lowering drugs as primary prevention in general practice: do patients reach guideline goals and continue treatment? ADDITION Denmark.

Graversen L, Christensen B, Borch-Johnsen K, Lauritzen T, Sandbaek A.

Scand J Prim Health Care. 2011 Dec;29(4):216-21. doi: 10.3109/02813432.2011.629148.

10.
11.

Medication adherence: WHO cares?

Brown MT, Bussell JK.

Mayo Clin Proc. 2011 Apr;86(4):304-14. doi: 10.4065/mcp.2010.0575.

12.

Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study.

Ruokoniemi P, Korhonen MJ, Helin-Salmivaara A, Lavikainen P, Jula A, Junnila SY, Kettunen R, Huupponen R.

Br J Clin Pharmacol. 2011 May;71(5):766-76. doi: 10.1111/j.1365-2125.2010.03895.x.

13.

Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.

Adamski J, Godman B, Ofierska-Sujkowska G, Osińska B, Herholz H, Wendykowska K, Laius O, Jan S, Sermet C, Zara C, Kalaba M, Gustafsson R, Garuolienè K, Haycox A, Garattini S, Gustafsson LL.

BMC Health Serv Res. 2010 Jun 7;10:153. doi: 10.1186/1472-6963-10-153. Review.

Items per page

Supplemental Content

Support Center